Safety and efficacy of etanercept in children with juvenile idiopathic arthritis below the age of 4
β Scribed by N. Tzaribachev; J. Kuemmerle-Deschner; M. Eichner; G. Horneff
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 209 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective Previous studies showed that etanercept treatment in patients with polyarticularβcourse juvenile rheumatoid arthritis (JRA) provided rapid clinical improvement that was sustained for up to 2 years. The goal of our study was to provide data on safety and efficacy after 4 ye
## Abstract ## Objective To determine whether vaccinations aggravate the course of autoimmune diseases such as juvenile idiopathic arthritis (JIA) and whether the immune response to vaccinations may be hampered by immunosuppressive therapy for the underlying disease. ## Methods In this multicent